Our Team
Saul N. Weingart, MD, PhD
Vice President for Quality Improvement and Patient Safety and Director of the Center
for Patient Safety
Dr. Weingart serves as Vice President for Quality Improvement and Patient Safety and Director of the Center for Patient Safety at Dana-Farber Cancer
Institute. He is an Associate Professor of Medicine at Harvard Medical
School and practices primary care internal medicine at Beth Israel
Deaconess Medical Center. Prior to joining Dana-Farber in 2004, Dr.
Weingart was Director of Patient Safety in the Division of General
Medicine at Beth Israel Deaconess Medical Center. He also served as Medical Director of Patient Safety for CareGroup Healthcare System.
He holds a doctorate in public policy from Harvard's John F.
Kennedy School of Government and a medical degree from the
University of Rochester. He completed an internal medicine
residency and general medicine fellowship at Beth Israel Deaconess
Medical Center and Harvard Medical School.
Dr. Weingart's research interests include the development of
voluntary reporting systems for medical errors, patient and
clinician participation in the prevention of adverse events in
health care, and executive leadership in patient safety.
Sharon Lane, RN, MSN
Senior Director
Sharon Lane is the Senior Director of the Center for Patient
Safety. She received her bachelor's degree in nursing from Simmons
College and master's degree in nursing from the University of
Massachusetts, Boston, as a Clinical Nurse Specialist concentrating
in critical care oncology. Sharon has been a nurse at Dana-Farber
Cancer Institute since 1989, serving in many staff and leadership
positions over the years. Prior to this position she was the
Director of Clinical Trials Nursing for six years. Sharon has
presented locally and nationally on the subject of safe practices
in chemotherapy administration. She was the lead faculty advisor
and presenter for the Oncology Nursing Society educational video,
"Preventing Medication Errors for the Oncology Nurse." At the
Center for Patient Safety, Sharon concentrates on operational
initiatives such as team training, improving medication safety,
nursing interventions, and executive walk rounds.
Daniela Brouillard
Executive Assistant
Before becoming Executive Assistant for the Center for
Patient Safety, Daniela Brouillard worked as an account coordinator
at Euro RSCG Life Managed Edge, a managed care consulting firm in
New York City. She also has several years' experience working in
medical education and not-for-profit organizations. She received
her bachelor's degree from the New School for Social Research in
New York. At the Center for Patient Safety, she is involved in hand
hygiene, oral chemotherapy safety, and medication reconciliation
initiatives.
Angela Cleary, RN, MSN
Program Manager
Angela Cleary is a Program Manager at the center. She received
her bachelor's degree from the University of Wisconsin at Madison
and her MSN from Northeastern University. She worked as a staff
nurse for seven years in medical/surgical oncology and bone marrow
transplant. She served as traveling nurse for Newton-Wellesley
Hospital, Massachusetts General Hospital, and Brigham and Women's
Hospital. Since leaving staff nursing, she has worked in research,
education, and the insurance sector. She participated in medication
error studies in oncology at Dana-Farber before joining the center
in 2005. She works on initiatives in medication safety and
performance measurement.
Thomas Isaac, MD, MBA, MPH
Consultant Research Scientist
Dr. Isaac is an Instructor in Medicine at Harvard Medical School
and a primary care physician at Beth Israel Deaconess Medical Center
(BIDMC).
Sherri O. Stuver, ScD
Associate Director
Sherri Stuver is the Associate Director for the Center for Patient Safety. She
also holds an appointment as an Associate Professor in the
Department of Epidemiology at Boston University School of Public
Health, where she has taught and conducted research since 2002.
Trained as a cancer epidemiologist, she earned her ScD from Harvard
School of Public Health and served on faculty at the school for thirteen years. Her research has primarily focused on oncogenic viruses and
their related malignancies, with an emphasis on human
T-lymphotropic virus type I and hepatitis C virus infections; she
also has done some work on the etiology of breast cancer. At the
Center for Patient Safety, Dr. Stuver will be involved in research
projects related to pain and pain management in cancer patients, and
to missed/delayed breast cancer diagnoses.
Andrew Seger, PharmD
Consultant Pharmacist
Andrew is Senior Research Pharmacist at Brigham and Women's
Hospital.
Junya Zhu, RN, MS
Research Scientist
Junya Zhu is a Research Scientist at the Center and a doctoral
candidate in Health Policy at Brandeis University. She also serves
as the Principal Investigator for a World Health
Organization-funded project in developing a valid patient safety
culture instrument in Chinese. She received her MS in International
Health Policy and Management and MA in Health Policy from Brandeis
University.
Before coming to the U.S. in 2005, she served in several staff
and leadership positions in a teaching hospital in China. During
her last tenure as the Director of Quality Improvement, she founded
and led a hospital accreditation project, paving the way for the
hospital to become one of the China's first Joint Commission
International-accredited hospitals.
Her research interests include patient safety and performance
measurement. At the Center, she works on a variety of projects,
including patient participation in the prevention of adverse
events, pain and pain management in cancer patients, and
missed/delayed breast cancer diagnoses.